Benzinga | May 12, 2021 04:16PM EDT

Kezar Life Sciences Q1 EPS $(0.25) Up From $(0.30) YoY

Kezar Life Sciences (NASDAQ:KZR) reported quarterly losses of $(0.25) per share. This is a 16.67 percent increase over losses of $(0.30) per share from the same period last year.